| Tutorials: | |
| 09:30 AM‑10:30 AM: | A Practical Review of Real World Data for Effectiveness Decisions – Case Studies of Using Historical Data in Developing Novel Therapies by DIA NEED
Chenkun Wang and Ziliang Li |
| 11:00 AM-12:00 PM: | Artificial Intelligence and its Impact on Clinical trials
Stephan Ogenstad |
| 1:00 PM-2:00 PM: | Power Considerations for Clinical Trials in Presence of Multiplicity
Kaushik Patra |
| 2:00 PM-4:00 PM: | Data Visualization for Clinical Results
Zachary Skrivanek |
| 04:00 PM-05:00 PM: | Assessing Treatment Effect Using Propensity Score Matching within the U.K. Population of Crohn's Disease Patients
Laura Gunn |
| Tuesday |
| 08:30 AM-09:30 AM: | Adaptive Design with Recurrent Event Outcome
Pranab Ghosh |
| 09:30 AM-10:30 AM: | Taking Adherence, PROs and RWD into Account in Clinical Trials
Alan Menius |
| 10:45 AM-11:45 AM: | Aggregate Safety Analysis for Causality Assessments of SAEs
Lothar Tremmel |
| 01:00 PM-02:00 PM: | Overview of Some Key Methods for Observational Settings
Shankar Srinivasan |
| 02:00 PM-03:00 PM: | Innovative Designs for Drug Development in Rare Diseases
Qing Liu |
| 03:30 PM-04:30 PM: | Implementing a Multi-attribute Model for Evaluating Alternative or Additional Indications in Drug Development
Jack Knorr |
| 04:30 PM-05:30 PM: | BASS Poster Session |
| Wednesday |
| 08:30 AM-09:30 AM: | Adjusting for Covariates in Randomized Clinical Trials for Drugs and Biologics with Continuous Outcomes Guidance for Industry
Daniel Rubin |
| 09:30 AM‑10:30 AM: | Adaptive Design Clinical Trials for Drugs and Biologics
Greg Levin |
| 10:45 AM‑11:45 AM: | Biomarker Data Analysis
Kao-Tai Tsai |
